de Marinis F, Kim TM, Bonanno L, Cheng S, et al. Savolitinib plus osimertinib in epidermal growth factor receptor (EGFR)-mutated advanced non-small cell lung cancer with MET overexpression and/or amplification following disease progression on osimertinib: primary results from the phase II SAVANNAH s Ann Oncol 2025 May 22:S0923-7534(25)00157-7. doi: 10.1016/j.annonc.2025.
PMID: 40461383